Fib-Col is contraindicated in patients with: Known hypersensitivity to fenofibrate or to any of the excipients of Fib-Col.
Severe renal dysfunction.
Hepatic dysfunction including primary biliary cirrhosis and unexplained persistent liver function abnormality.
Pre-existing gallbladder disease.
Children.
Known photo allergy or phototoxic reaction during treatment with fenofibrate or ketoprofen.
Chronic or acute pancreatitis with the exemption of acute pancreatitis due to severe hypertriglyceridemia.